QUOTE AND NEWS
Benzinga  4 hrs ago  Comment 
SXC Health Solutions Corp. (NASDAQ: SXCI) announced yesterday the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 5,200,000 of its common shares at a price to the public of $90.60 per share....
Benzinga  May 9  Comment 
SXC Health Solutions Corp. (NASDAQ: SXCI) announced today that it has commenced an underwritten public offering of 4,340,000 of its common shares. In connection with the offering, SXC will grant the underwriters a 30-day option to purchase up to...
Benzinga  May 7  Comment 
Scotia Capital Markets raises its price target from $103 to $106 on Sector-Perform-rated SXC Health Solutions (NASDAQ: SXCI). Scotia Capital Markets notes, "In our view, SXC remains a growth story with good defensive characteristics, given its...
Benzinga  May 3  Comment 
SXC Health Solutions Corp (NASDAQ: SXCI) reported a 44% surge in its first-quarter profit. SXC Health's quarterly net income climbed to $26.3 million, or $0.42 per share, versus $18.3 million, or $0.29 per share, in the year-earlier...
PR Newswire  Apr 19  Comment 
BALA CYNWYD, Pa., April 19, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Catalyst Health Solutions, Inc. ("Catalyst" or the "Company") (Nasdaq: CHSI)
Benzinga  Apr 19  Comment 
Jefferies increases its price from $80 to $110 on Buy-rated SXC Health Solutions (NASDAQ: SXCI) as CHSI acquisitions should help the company play a more aggressive defense. Jefferies notes, "We view SXC's pending acquisition of CHSI as a...
MarketWatch  Apr 18  Comment 
Shares of pharmacy benefit managers Catalyst Health Solutions and SXC Health Solutions surge after the companies announce merger plans.
StreetInsider.com  Apr 18  Comment 
SXC Health Solutions Corp. (Nasdaq: SXCI) and Catalyst Health Solutions, Inc. (Nasdaq: CHSI) Boards of Directors unanimously approved a definitive merger agreement under which SXC and Catalyst will combine in a cash and stock transaction valued at...
Wall Street Journal  Apr 18  Comment 
Pharmacy-benefits manager SXC agreed to buy Catalyst Health in a roughly $4.14 billion cash-and-stock deal.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki